{"entity":{"type":"insider","cik":"0001461736","url":"/insider/0001461736","json_url":"/insider/0001461736.json","name":"Hopkins Robert O","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2019-03-22","last":"2020-11-24","span_basis":"filed_date"},"name_variants":[{"name":"Hopkins Robert O","source":"filing","n_filings":11,"first_seen":"2019-03-22","last_seen":"2020-11-24"}],"transactions":[{"id":3013993,"accession":"0001593968-20-002245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002245","line_url":"/filing/0001593968-20-002245#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":0.4052,"price_display":"0.41","price_state":"stated","total_value":14182.0,"total_display":"14,182.00","total_whole":"14,182","shares_owned_after":254810.0,"shares_owned_after_display":"254,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-20","filed_date":"2020-11-24","scope":"insider"},{"id":3300560,"accession":"0001593968-20-002231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002231","line_url":"/filing/0001593968-20-002231#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7229.0,"shares_display":"7,229","price_per_share":0.4061,"price_display":"0.41","price_state":"stated","total_value":2935.6969,"total_display":"2,935.70","total_whole":"2,936","shares_owned_after":289810.0,"shares_owned_after_display":"289,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-20","scope":"insider"},{"id":3300522,"accession":"0001593968-20-001950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001950","line_url":"/filing/0001593968-20-001950#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":274781.0,"shares_owned_after_display":"274,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-10-01","scope":"insider"},{"id":3314613,"accession":"0001593968-20-001773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001773","line_url":"/filing/0001593968-20-001773#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7418.0,"shares_display":"7,418","price_per_share":0.8741,"price_display":"0.87","price_state":"stated","total_value":6484.0738,"total_display":"6,484.07","total_whole":"6,484","shares_owned_after":294781.0,"shares_owned_after_display":"294,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2116695,"accession":"0001593968-20-001225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001225","line_url":"/filing/0001593968-20-001225#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6532.0,"shares_display":"6,532","price_per_share":0.5601,"price_display":"0.56","price_state":"stated","total_value":3658.5732,"total_display":"3,658.57","total_whole":"3,659","shares_owned_after":302199.0,"shares_owned_after_display":"302,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":3300354,"accession":"0001593968-20-000862","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000862","line_url":"/filing/0001593968-20-000862#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8749.0,"shares_display":"8,749","price_per_share":0.3366,"price_display":"0.34","price_state":"stated","total_value":2944.9134,"total_display":"2,944.91","total_whole":"2,945","shares_owned_after":308731.0,"shares_owned_after_display":"308,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-19","scope":"insider"},{"id":2532958,"accession":"0001593968-20-000522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000522","line_url":"/filing/0001593968-20-000522#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8420.0,"shares_display":"8,420","price_per_share":0.6035,"price_display":"0.60","price_state":"stated","total_value":5081.47,"total_display":"5,081.47","total_whole":"5,081","shares_owned_after":317480.0,"shares_owned_after_display":"317,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-26","scope":"insider"},{"id":8536708,"accession":"0001593968-19-002189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-002189","line_url":"/filing/0001593968-19-002189#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7347.0,"shares_display":"7,347","price_per_share":0.8301,"price_display":"0.83","price_state":"stated","total_value":6098.7447,"total_display":"6,098.74","total_whole":"6,099","shares_owned_after":325900.0,"shares_owned_after_display":"325,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":7791775,"accession":"0001593968-19-001779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001779","line_url":"/filing/0001593968-19-001779#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7101.0,"shares_display":"7,101","price_per_share":1.0613,"price_display":"1.06","price_state":"stated","total_value":7536.2913,"total_display":"7,536.29","total_whole":"7,536","shares_owned_after":333247.0,"shares_owned_after_display":"333,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":7898293,"accession":"0001593968-19-001168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001168","line_url":"/filing/0001593968-19-001168#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7559.0,"shares_display":"7,559","price_per_share":1.7342,"price_display":"1.73","price_state":"stated","total_value":13108.8178,"total_display":"13,108.82","total_whole":"13,109","shares_owned_after":340348.0,"shares_owned_after_display":"340,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":8140339,"accession":"0001593968-19-000834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-000834","line_url":"/filing/0001593968-19-000834#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001461736","owner_name":"Hopkins Robert O","owner_display_name":"Hopkins Robert O","owner_url":"/insider/0001461736","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8900.0,"shares_display":"8,900","price_per_share":2.2973,"price_display":"2.30","price_state":"stated","total_value":20445.97,"total_display":"20,445.97","total_whole":"20,446","shares_owned_after":347907.0,"shares_owned_after_display":"347,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000887247","name":"Adamis Pharmaceuticals Corp","url":"/issuer/0000887247","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2019-03-22","last_seen":"2020-11-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001461736","retrieved_at":"2026-08-25T19:09:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}